Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults.
J Am Acad Dermatol. 2016 Sep;75(3):494-503.e6. doi: 10.1016/j.jaad.2016.05.046. Epub 2016 Jul 11.
J Am Acad Dermatol. 2016.
PMID: 27417017
Free article.
Clinical Trial.
Long-term safety of crisaborole ointment 2% in children and adults with mild to moderate atopic dermatitis.
Eichenfield LF, Call RS, Forsha DW, Fowler J Jr, Hebert AA, Spellman M, Stein Gold LF, Van Syoc M, Zane LT, Tschen E.
Eichenfield LF, et al. Among authors: forsha dw.
J Am Acad Dermatol. 2017 Oct;77(4):641-649.e5. doi: 10.1016/j.jaad.2017.06.010. Epub 2017 Aug 18.
J Am Acad Dermatol. 2017.
PMID: 28823881
Free article.
Item in Clipboard
Glycopyrronium tosylate in pediatric primary axillary hyperhidrosis: Post hoc analysis of efficacy and safety findings by age from two phase three randomized controlled trials.
Hebert AA, Glaser DA, Green L, Werschler WP, Forsha DW, Drew J, Gopalan R, Pariser DM.
Hebert AA, et al. Among authors: forsha dw.
Pediatr Dermatol. 2019 Jan;36(1):89-99. doi: 10.1111/pde.13723. Epub 2018 Nov 19.
Pediatr Dermatol. 2019.
PMID: 30451318
Free PMC article.
Clinical Trial.
Item in Clipboard
Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis.
Bieber T, Simpson EL, Silverberg JI, Thaçi D, Paul C, Pink AE, Kataoka Y, Chu CY, DiBonaventura M, Rojo R, Antinew J, Ionita I, Sinclair R, Forman S, Zdybski J, Biswas P, Malhotra B, Zhang F, Valdez H; JADE COMPARE Investigators.
Bieber T, et al.
N Engl J Med. 2021 Mar 25;384(12):1101-1112. doi: 10.1056/NEJMoa2019380.
N Engl J Med. 2021.
PMID: 33761207
Clinical Trial.
Item in Clipboard
Once-Daily Oral Sarecycline 1.5 mg/kg/day Is Effective for Moderate to Severe Acne Vulgaris: Results from Two Identically Designed, Phase 3, Randomized, Double-Blind Clinical Trials.
Moore A, Green LJ, Bruce S, Sadick N, Tschen E, Werschler P, Cook-Bolden FE, Dhawan SS, Forsha D, Gold MH, Guenthner S, Kempers SE, Kircik LH, Parish JL, Rendon MI, Rich P, Stein-Gold L, Tyring SK, Weiss RA, Nasir A, Schmitz C, Boodhoo TI, Kaoukhov A, Berk DR.
Moore A, et al.
J Drugs Dermatol. 2018 Sep 1;17(9):987-996.
J Drugs Dermatol. 2018.
PMID: 30235387
Clinical Trial.
Item in Clipboard
Cite
Cite